The determination in plasma and pharmacokinetics of ondansetron
Affiliations
- PMID: 2533903
Item in Clipboard
The determination in plasma and pharmacokinetics of ondansetron
Eur J Cancer Clin Oncol.
1989.
Abstract
High performance liquid chromatography has been found to be an accurate method for determination of ondansetron in plasma. Within a single assay, and between assays, the differences between theoretical and observed means obtained from analysis of spiked samples were low and good precision was obtained. The method has been used to assay several thousand samples from subjects included in pharmacokinetic studies. The pharmacokinetic profile of ondansetron has been established following single and multiple oral dosing and intravenous infusions.
Similar articles
-
The metabolism of ondansetron.Eur J Cancer Clin Oncol. 1989;25 Suppl 1:S75-7. Eur J Cancer Clin Oncol. 1989. PMID: 2533904
-
Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability.Biopharm Drug Dispos. 2008 Oct;29(7):414-26. doi: 10.1002/bdd.628. Biopharm Drug Dispos. 2008. PMID: 18697186
-
Simultaneous determination of ondansetron and tropisetron in human plasma using HPLC with UV detection.Biomed Chromatogr. 2002 May;16(3):187-90. doi: 10.1002/bmc.125. Biomed Chromatogr. 2002. PMID: 11920943
-
The clinical pharmacology of ondansetron.Eur J Cancer Clin Oncol. 1989;25 Suppl 1:S21-4; discussion S25-7. Eur J Cancer Clin Oncol. 1989. PMID: 2533895 Review.
-
Development and validation of a rapid 96-well format based liquid-liquid extraction and liquid chromatography-tandem mass spectrometry analysis method for ondansetron in human plasma.J Chromatogr B Analyt Technol Biomed Life Sci. 2006 May 19;836(1-2):79-82. doi: 10.1016/j.jchromb.2006.03.032. Epub 2006 Apr 11. J Chromatogr B Analyt Technol Biomed Life Sci. 2006. PMID: 16581316
Cited by
-
Ondansetron. Therapeutic use as an antiemetic.Drugs. 1991 Apr;41(4):574-95. doi: 10.2165/00003495-199141040-00006. Drugs. 1991. PMID: 1711961 Review.
-
Concentration of ondansetron in cerebrospinal fluid following oral dosing in volunteers.Psychopharmacology (Berl). 1992;109(4):497-8. doi: 10.1007/BF02247730. Psychopharmacology (Berl). 1992. PMID: 1365869 Clinical Trial.
-
Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study. Ondansetron Study Group.Br J Cancer. 1992 Jul;66(1):192-7. doi: 10.1038/bjc.1992.241. Br J Cancer. 1992. PMID: 1386245 Free PMC article. Clinical Trial.
-
Placental transfer of ondansetron during early human pregnancy.Clin Pharmacokinet. 2006;45(4):419-23. doi: 10.2165/00003088-200645040-00006. Clin Pharmacokinet. 2006. PMID: 16584287 Clinical Trial.
-
Cardiovascular stability with rapid intravenous infusion of ondansetron.Can J Anaesth. 1993 May;40(5 Pt 1):448-52. doi: 10.1007/BF03009516. Can J Anaesth. 1993. PMID: 8513525 Clinical Trial.